Dr. C. Ola Landgren on Quadruple Therapies and the Future of Multiple Myeloma Treatment – InventUM
Dr. C. Ola Landgren, will present an overview of new multiple myeloma studies at the annual meeting of ASCO.
Dr. C. Ola Landgren, will present an overview of new multiple myeloma studies at the annual meeting of ASCO.
Nature Medicine – In an ongoing phase 1 trial, the combination of two new immunotherapies targeting CTLA-4 and PD-1 was overall well tolerated and elicited…
Blood Cancer Journal – Impact of Extraosseous Extramedullary Disease on Outcomes of Patients with Relapsed-Refractory Multiple Myeloma receiving Standard-of-Care Chimeric Antigen Receptor T-Cell…
This cross-sectional study evaluates associations between polygenic scores with psychiatric disorder symptoms and relevant comorbid phenotypes.
Chandler Park: When to order FDG-PET scans / Aman Chauhan, cancer, Chandler Park, FDG PET, neuroendocrine tumors, OncoDaily, Oncology
Objectives: During the COVID-19 pandemic, BMJ, the premier journal on evidence-based medicine worldwide, published many views by advocates of specific COVID-19 policies. We aimed to…
With missing defendants, dodgy video links and crumbling walls, a typical day at Snaresbrook show why 68,125 cases are waiting to be heard in England…
As the UK election campaign ramps up, here’s how to spot what you can trust on your social media feeds | ITV National News
The long-term follow-up results of CASSIOPEIA show that including daratumumab in both the induction and consolidation phase and the maintenance phase led to superior progression-free…
Insights and optimism from a prolific, world leading physician-scientist